The Journal of Alzheimer’s Disease (JAD) has announced a new partnership with the Advanced Continuing Education Association (ACEA) to provide a new series of fully accredited continuing medical education (CME) journal articles. The program, accredited under the ACCME and open to US and Canadian physicians, launched with 10 landmark articles published in JAD, each with a corresponding CME post-test providing 1.0 AMA PRA Category 1 Credit™.
The catalogue of currently available CME articles covers a broad range of important topics in AD and is posted on the JAD website at j-alz.com/cme-credits. New articles will be added to the program on an ongoing basis; all of these articles are freely available and thereby accessible by both journal subscribers and non-subscribers.
Readers can choose to invest a small fee to gain CME credit after reading an article. Participants who opt to join the ACEA community can receive additional support and access to improve their CME experience at no cost.
Now in its 22nd year of publication, the Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behaviour, treatment, and psychology of Alzheimer’s disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
